Loading insider details...
Beta
Latest Form 4 (Feb 12, 2026): Grant/Award of 455,000 LITS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 12, 2026 | Lite Strategy, Inc. (LITS) | Grant/Award | 455,000 | n/a |
| Nov 18, 2025 | Lite Strategy, Inc. (LITS) | Grant/Award | 635,000 | n/a |
| Jul 18, 2025 | MEI Pharma, Inc. (MEIP) | Grant/Award | 20,000 | n/a |
| Feb 23, 2022 | Evofem Biosciences, Inc. (EVFM) | Grant/Award | 450,000 | n/a |
| Jan 4, 2022 | Evofem Biosciences, Inc. (EVFM) | Disposition to Issuer | 120,000 | n/a |
| Dec 20, 2021 | Evofem Biosciences, Inc. (EVFM) | Purchase | 40,594 | $15.0K |
| Jun 10, 2021 | Evofem Biosciences, Inc. (EVFM) | Purchase | 24,500 | $25.2K |
| May 21, 2021 | Evofem Biosciences, Inc. (EVFM) | Tax Withholding | 42,280 | $36.4K |
| Feb 4, 2021 | Evofem Biosciences, Inc. (EVFM) | Grant/Award | 200,000 | n/a |
| Nov 18, 2020 | Evofem Biosciences, Inc. (EVFM) | Purchase | 7,760 | $16.8K |